(Food-Beverage-News.Com, December 15, 2021 ) The specialty enzymes market is estimated to be valued at USD 4.4 billion in 2019 and is projected to reach USD 6.6 billion by 2025, recording a CAGR of 6.9% in terms of value. The growing concerns about the enzyme quality in pharmaceuticals & diagnostics and rise in demand for non-harmful biological catalysts are factors that are projected to drive the growth of the specialty enzymes market, globally.
By type, the polymerases & nucleases segment is projected to account for the largest share in the specialty enzymes market during the forecast period
The polymerases & nucleases segment is projected to dominate the market during the forecast period. Polymerases & nucleases are used in specialty applications, such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. Polymerases & nucleases have been grouped together as they both work on nucleic acid polymers such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA), and are commonly used in similar applications. These types of enzymes catalyze the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) polymers, as they are essential for all nucleic acid processing, including replication, repair, recombination, and transcription.
By application, the pharmaceuticals segment accounted for the largest market size in the specialty enzymes market during the forecast period
The demand for specialty enzymes is increasing significantly due to the increasing application of enzymes in the pharmaceutical industry. Specialty enzyme usage in the pharmaceutical industry is mainly for drug manufacture, disease diagnostics, or as therapy. Increasing incorporation of enzymes in therapies for diseases such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management, among others, is a factor that fuels market demand.
North America is projected to account for the largest market share during the forecast period
In 2018, North America accounted for the largest market share in the specialty enzymes market. Technological advancements in this region have made enzymes available for a wide range of applications, and this segment is estimated to drive the growth of the market in the region. This region is projected to be the largest market due to the development of novel and superior performing products and global industrialization. The pharmaceutical industry in this region is also witnessing a rise in the usage of enzymes. The US is the dominant country, and the market in this region has reached its maturity. These factors are projected to contribute to the growth of the North American market.
Key players in the global market include BASF (Germany), DuPont (US), Roche Holding (Switzerland), Novozymes (Denmark), DSM (Netherlands), Sanofi (France), and Codexis (US).
